{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:55:47Z","timestamp":1788285347889,"version":"build-2803163510"},"reference-count":30,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HAB"],"published-print":{"date-parts":[[2023,5,15]]},"abstract":"<jats:p>BACKGROUND: One of the most severe side effects of solid-organ transplantation is posttransplant lymphoproliferative disease (PTLD). People with human immunodeficiency virus infection (HIV), an immunosuppressive disease comparable to HIV, have a higher chance of developing lymphoma when their peripheral blood contains elevated levels of the immunoglobulins kappa and lambda free light chains (FLCs). METHODS: This systematic review\u2019s objective was to monitor associated B lymphoma cells in PTLD patients. In order to find relevant studies published between 1\/1\/2000 and 1\/9\/2022, two independent researchers conducted searches (MT, AJ). A literature search of English language publications was conducted using MEDLINE through PubMed, EMBASETM through Ovid, the Cochrane Library, and Trip. In addition to Magiran and SID, we searched KoreaMed and LILACS for literature published in other languages. sFLC or PTLD, transplant, or Electrophoresis are terms used in the search strategy. RESULTS: A total of 174 studies were selected. After analyzing their correspondence with the required criteria, a final review of five studies was conducted. The manuscript presents current findings on the potential benefits of the clinical applicability of sFLCs in PTLD. While the preliminary results appear promising, the only consistent result is that early-onset PTLD is predicted within the first two years after transplant, a biomarker that could be used to diagnose the condition. CONCLUSIONS: Therefore, PTLD has been predicted by using the sFLCs. There have been contradictory results to date. Future research could include assessing the quantity of sFLCs and their quality in transplant recipients. In addition to PTLD and complications after transplantation, sFLCs may provide insight into other diseases. To confirm the validity of sFLCs, more studies are needed.<\/jats:p>","DOI":"10.3233\/hab-220016","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T14:45:52Z","timestamp":1680619552000},"page":"183-194","source":"Crossref","is-referenced-by-count":1,"title":["Non-invasive monitoring associated with B lymphoma cells in post-transplant lymphoproliferative disorder (PTLD) patients: Systematic review"],"prefix":"10.1177","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7993-2681","authenticated-orcid":false,"given":"Naser","family":"Honar","sequence":"first","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Namazi Teaching Hospital, Abu Ali Sina for Medicine & Organ Transplant, Shiraz University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4134-1405","authenticated-orcid":false,"given":"Iraj","family":"Shahramian","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Namazi Teaching Hospital, Abu Ali Sina for Medicine & Organ Transplant, Shiraz University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4610-0413","authenticated-orcid":false,"given":"Mohammad Hadi","family":"Imanieh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Namazi Teaching Hospital, Abu Ali Sina for Medicine & Organ Transplant, Shiraz University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1876-5266","authenticated-orcid":false,"given":"Maryam","family":"Ataollahi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Namazi Teaching Hospital, Abu Ali Sina for Medicine & Organ Transplant, Shiraz University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0213-9087","authenticated-orcid":false,"given":"Masoud","family":"Tahani","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology and Hepatology Research Center, Zabol University of Medical Sciences, Zabol, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6809-175X","authenticated-orcid":false,"given":"Shiva","family":"Rakhshaninasab","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology and Hepatology Research Center, Zabol University of Medical Sciences, Zabol, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-6409","authenticated-orcid":false,"given":"Amin","family":"Javadifar","sequence":"additional","affiliation":[{"name":"Immunology Research Center, Inflammation and Inflammatory Diseases Division, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"2","key":"10.3233\/HAB-220016_ref1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1470-2045(11)70300-X","article-title":"Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial","volume":"13","author":"Trappe","year":"2012","journal-title":"The Lancet Oncology"},{"issue":"7","key":"10.3233\/HAB-220016_ref2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"3","key":"10.3233\/HAB-220016_ref3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/bjh.15263","article-title":"Management of post-transplant lymphoproliferative disorders","volume":"182","author":"DeStefano","year":"2018","journal-title":"British Journal of Haematology"},{"issue":"9","key":"10.3233\/HAB-220016_ref4","doi-asserted-by":"crossref","first-page":"e13652","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clinical Transplantation"},{"issue":"1","key":"10.3233\/HAB-220016_ref5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41409-019-0548-7","article-title":"Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities","volume":"55","author":"Al Hamed","year":"2020","journal-title":"Bone Marrow Transplantation"},{"issue":"9","key":"10.3233\/HAB-220016_ref6","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1097\/TP.0000000000001767","article-title":"The immune response to Epstein Barr virus and implications for posttransplant lymphoproliferative disorder","volume":"101","author":"Martinez","year":"2017","journal-title":"Transplantation"},{"key":"10.3233\/HAB-220016_ref7","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00432-018-2674-9","article-title":"The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients","volume":"144","author":"Wareham","year":"2018","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.3233\/HAB-220016_ref8","doi-asserted-by":"crossref","unstructured":"T.Y. Park, S.Y. Kim, S.H. Bae and S.Y. Han, An Atypical Subcutaneous Cytomegalovirus Infection Mimicking a Post-transplant Lymphoproliferative Disorder in a Solid Organ Transplant Recipient, Iranian Journal of Radiology 19(1) (2022).","DOI":"10.5812\/iranjradiol.117498"},{"issue":"3","key":"10.3233\/HAB-220016_ref9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/TP.0b013e318274ab63","article-title":"Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipients","volume":"95","author":"Engels","year":"2013","journal-title":"Transplantation"},{"key":"10.3233\/HAB-220016_ref10","doi-asserted-by":"crossref","unstructured":"E.A. Engels, L.W. Jennings, M.J. Everly, O. Landgren, K. Murata and E.L. Yanik, Donor-specific antibodies, immunoglobulin-free light chains, and BAFF levels in relation to risk of late-onset PTLD in liver recipients, Transplantation Direct 4(6) (2018 Jun).","DOI":"10.1097\/TXD.0000000000000792"},{"key":"10.3233\/HAB-220016_ref11","doi-asserted-by":"crossref","first-page":"101229","DOI":"10.1016\/j.trim.2019.101229","article-title":"Immunoglobulin abnormalities in 1677 solid organ transplant recipients. Implications for posttransplantation follow-up","volume":"57","author":"Se\u010dn\u00edk","year":"2019","journal-title":"Transplant Immunology"},{"issue":"1","key":"10.3233\/HAB-220016_ref12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/bjc.2013.294","article-title":"Risk of lymphoma subtypes after solid organ transplantation in the United States","volume":"109","author":"Clarke","year":"2013","journal-title":"British Journal of Cancer"},{"issue":"9","key":"10.3233\/HAB-220016_ref13","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.110.218438","article-title":"Effects of free immunoglobulin light chains on viral myocarditis","volume":"106","author":"Matsumori","year":"2010","journal-title":"Circulation Research"},{"issue":"2","key":"10.3233\/HAB-220016_ref14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"issue":"5","key":"10.3233\/HAB-220016_ref15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2009.25.1322","article-title":"Circulating serum free light chains as predictive markers of AIDS-related lymphoma","volume":"28","author":"Landgren","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.3233\/HAB-220016_ref16","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3109\/10428194.2013.764423","article-title":"Serum free light chains and post-transplant lymphoproliferative disorder in patients with renal transplant","volume":"54","author":"Fernando","year":"2013","journal-title":"Leukemia & Lymphoma"},{"issue":"6","key":"10.3233\/HAB-220016_ref17","doi-asserted-by":"crossref","first-page":"e14286","DOI":"10.1111\/ctr.14286","article-title":"Serum free light chains in solid organ transplant recipients","volume":"35","author":"Kwapisz","year":"2021","journal-title":"Clinical Transplantation"},{"issue":"1","key":"10.3233\/HAB-220016_ref18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/bmt.2014.213","article-title":"Serum immunoglobulin free light chains and post-transplant lymphoproliferative disorder among allogeneic hematopoietic stem cell transplant recipients","volume":"50","author":"Engels","year":"2015","journal-title":"Bone Marrow Transplantation"},{"issue":"7","key":"10.3233\/HAB-220016_ref19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00467-019-04284-w","article-title":"Biomarkers for PTLD diagnosis and therapies","volume":"35","author":"Martinez","year":"2020","journal-title":"Pediatric Nephrology"},{"issue":"12","key":"10.3233\/HAB-220016_ref20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/ajh.23839","article-title":"Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B-and T-cell non-H odgkin lymphoma","volume":"899","author":"Witzig","year":"2014","journal-title":"American Journal of Hematology"},{"issue":"2","key":"10.3233\/HAB-220016_ref21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/bjh.13213","article-title":"Managing the challenge of PTLD in liver and bowel transplant recipients","volume":"169","author":"Lauro","year":"2015","journal-title":"British Journal of Haematology"},{"issue":"11","key":"10.3233\/HAB-220016_ref22","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1515\/cclm-2022-0503","article-title":"Detection of a monoclonal component after pediatric liver transplantation: a case report","volume":"60","author":"Vasco","year":"2022","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"key":"10.3233\/HAB-220016_ref23","doi-asserted-by":"crossref","unstructured":"B. Fakhri, M. Fiala, M. Slade, P. Westervelt and A. Ghobadi, Donor-derived smoldering multiple myeloma following a hematopoietic cell transplantation for AML, Case Reports in Hematology 2017 (2017 Feb).","DOI":"10.1155\/2017\/3728429"},{"issue":"2","key":"10.3233\/HAB-220016_ref24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.21911","article-title":"Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in US kidney recipients","volume":"86","author":"Quinlan","year":"2011","journal-title":"American Journal of Hematology"},{"issue":"5","key":"10.3233\/HAB-220016_ref25","first-page":"298","article-title":"Appendectomy in pregnancy and postpartum: analysis of data from a large private hospital","volume":"3","author":"Nunnelee","year":"1999","journal-title":"Clinical Excellence for Nurse Practitioners: The International Journal of NPACE"},{"issue":"5","key":"10.3233\/HAB-220016_ref26","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1600-6143.2011.03954.x","article-title":"Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder","volume":"12","author":"Engels","year":"2012","journal-title":"American Journal of Transplantation"},{"key":"10.3233\/HAB-220016_ref27","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00277-018-03591-w","article-title":"Serum-free light chains adjusted for renal function are a potential biomarker for post-transplant lymphoproliferative disorders","volume":"98","author":"Borrows","year":"2019","journal-title":"Annals of Hematology"},{"issue":"4","key":"10.3233\/HAB-220016_ref28","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","author":"Bradwell","year":"2001","journal-title":"Clinical chemistry"},{"issue":"21","key":"10.3233\/HAB-220016_ref29","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1182\/blood.V124.21.5883.5883","article-title":"Comparison of Free Light Chain Assay with Protein Electrophoresis for Screening and Monitoring PTLD","volume":"124","author":"Kuhn","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.3233\/HAB-220016_ref30","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1046\/j.1600-6143.2003.00219.x","article-title":"Use of Serum Protein Electrophoresis to Monitor Patients with Post-transplant Lymphoproliferative Disorder","volume":"3","author":"Aqui","year":"2003","journal-title":"American Journal of Transplantation"}],"container-title":["Human Antibodies"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/HAB-220016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:22:41Z","timestamp":1777447361000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/HAB-220016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":30,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/hab-220016","relation":{},"ISSN":["1875-869X","1093-2607"],"issn-type":[{"value":"1875-869X","type":"electronic"},{"value":"1093-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,15]]}}}